Eidos Therapeutics, Inc. Current Ratio 2018-2020 | EIDX
Eidos Therapeutics, Inc. current ratio from 2018 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2020-09-30 | $0.15B | $0.01B | 11.11 |
| 2020-06-30 | $0.18B | $0.02B | 11.62 |
| 2020-03-31 | $0.20B | $0.01B | 16.97 |
| 2019-12-31 | $0.20B | $0.01B | 18.78 |
| 2019-09-30 | $0.17B | $0.01B | 17.00 |
| 2019-06-30 | $0.14B | $0.01B | 20.89 |
| 2019-03-31 | $0.15B | $0.01B | 19.04 |
| 2018-12-31 | $0.16B | $0.01B | 33.20 |
| 2018-09-30 | $0.17B | $0.01B | 28.07 |
| 2018-06-30 | $0.18B | $0.01B | 33.79 |
| 2018-03-31 | $0.03B | $0.01B | 5.48 |
| 2017-12-31 | $0.01B | $0.00B | 2.70 |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
| 2017-03-31 | $0.00B | 0.00 | |
